Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.64
-0.17 (-4.46%)
At close: Aug 14, 2025, 3:59 PM
3.67
0.82%
Pre-market: Aug 15, 2025, 09:12 AM EDT

Prime Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-195.88M -198.13M -121.82M -165.37M
Depreciation & Amortization
6.13M 4.65M 2.22M 568K
Stock-Based Compensation
26.07M 13.91M 6.46M 1.75M
Other Working Capital
36.33M -6.49M -37.86M 29.99M
Other Non-Cash Items
9.74M 11.79M 17.68M 98.42M
Deferred Income Tax
n/a -279K -964K -624K
Change in Working Capital
31.08M 2.65M -35.4M 31.18M
Operating Cash Flow
-122.86M -165.41M -131.83M -34.08M
Capital Expenditures
-7.29M -8.72M -16.09M -4.15M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-129.45M -104.95M -123.34M -81.98M
Sales Maturities Of Investments
204.2M 132.56M 93M 13M
Other Investing Acitivies
1M -170K -665K -496K
Investing Cash Flow
68.46M 18.71M -47.1M -73.63M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 655K -3.82M -1.09M
Financial Cash Flow
195.88M 655K 181.49M 269.28M
Net Cash Flow
141.47M -146.05M 2.57M 161.57M
Free Cash Flow
-130.16M -174.14M -147.92M -38.23M